Apim Therapeutics

Developer of anti-cancer therapies potentiating chemotherapy induced responses in cancer cells

placeTrondheim, Trondelag, Norway calendar_todayFounded 2009 groups1 employees language apimtherapeutics.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 541 times.

YearFilings
20121
20131
20141
20151
20161
20171
20181
20191
20201
20211
20221
20261

Investor mix

6 investors on record; lead investors include Sarsia Seed.

Investor typeCountShare
Venture capital467%
Angel & family office117%
Bank & private debt117%
Coming soon